Find and Pitch Jounalists, Get Your Story Covered

Tags: biotech biotechnology Cancer drug development Drug prices

	Profile	Recent Articles on Subject
1	STAT Staff STAT News Frontiers of health & medicine reporting. healthmedicinejournalism	STAT+: Biotech analyst Brian Skorney and CEO Daphne Zohar weigh in on election results - 9 days ago
2	Mario Aguilar STAT News Reporter at STATnews. Previous engagements noted. Personal views. Brooklyn techhealth care	The GLP-1 telehealth boom, Senate investigation of MA plans, and the fall of a cancer startup - about 1 month ago STAT+: AI leads the way as health tech funding inches toward a post-pandemic stability - 4 months ago
3	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	California is a life sciences leader. Joe Panetta has been one of its most vocal advocates. - about 2 months ago Who’s winning in biotech’s tight market? - 2 months ago Pharma’s ‘it’ therapy — a new drug class gaining steam - 2 months ago PharmaVoice 100s: Entrepreneurs - about 1 year ago
4	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders - 2 months ago
5	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope. - 3 months ago A potential MS ‘game changer’ could bring more safety to the table — even against viruses - 3 months ago The hunt for the brain’s biomarkers - 5 months ago 4 offbeat biotechs making a splash in the life sciences - 7 months ago What’s old is new: The revival of a one-time radiotherapy cancer treatment - 7 months ago These biotech hotspots are ripe for IPOs - 8 months ago
6	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Biotech led by J&J veterans launches with $165 million for cancer, autoimmune therapies - 4 months ago STAT+: Biotech incubator Curie.Bio graduates its first startup - about 1 year ago STAT+: Life science investors close nearly $6 billion in new funds - about 1 year ago
7	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	The biotech news you missed this week - 4 months ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 6 months ago How resurrecting extinct species might impact medicine - 8 months ago Lawmakers want to add more Chinese biotechs to defense list - 8 months ago How GLP-1’s moved from research labs to national TV - 8 months ago The Senate health committee looks into its first subpoena in 40 years - 10 months ago The biotech updates you need to read today - 11 months ago The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - 11 months ago FDA chastens pet companies over antibiotics - 11 months ago The biotech news you missed from the weekend - 11 months ago Novartis is building a new radioligand plant in China - 12 months ago Johnson & Johnson bets heavy on AI-driven drug discovery - 12 months ago Today’s biotech news roundup, in under 800 words - 12 months ago A new algorithm unveils CRISPR ‘treasure trove’ - 12 months ago These are the need-to-know biotech stories from this weekend - about 1 year ago The first vaccine for the increasingly prevalent chikungunya virus is here - about 1 year ago XBI biotech index rises, giving investors a shred of hope - about 1 year ago Want a biotech buyout? Target cancer - about 1 year ago
8	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	A biotech’s binary bet ends badly - 5 months ago STAT+: Weed for weight loss, and more from Biotech Land - 8 months ago
9	Sara Novak Discover Magazine Science journalist. Writer DiscoverMag. Sullivan's Island, South Carolina sciencejournalism	The Future of Organ-Chip Technology Is Bright - 5 months ago
10	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu - 6 months ago

Journalists covering biotech & health